drugset / Trial / NCT00854425

L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma

NCT00854425

Phase 2 Completed 40 enrolled Fudan University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and tolerability of L-asparaginase monotherapy as salvage treatment in patients with NK/T cell lymphoma

Timeline

Start
2008-06
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject asparaginase Protein / enzyme biologic 600 mg/m2

Indications